Clobetasol propionate and Skin blushing/flushing - a phase IV clinical study of FDA data

Summary:

Skin blushing/flushing is found among people who take Clobetasol propionate, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Clobetasol propionate and have Skin blushing/flushing. It is created by eHealthMe based on reports of 7,848 people who have side effects when taking Clobetasol propionate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 03, 2023

7,848 people reported to have side effects when taking Clobetasol propionate.
Among them, 46 people (0.59%) have Skin blushing/flushing.


What is Clobetasol propionate?

Clobetasol propionate has active ingredients of clobetasol propionate. It is often used in psoriasis. eHealthMe is studying from 8,114 Clobetasol propionate users for its effectiveness, alternative drugs and more.

What is Skin blushing/flushing?

Skin blushing/flushing (a sudden reddening of the face, neck) is found to be associated with 3,370 drugs and 2,771 conditions by eHealthMe.

Number of Clobetasol propionate and Skin blushing/flushing reports submitted per year:

Could Clobetasol propionate cause Skin blushing/flushing?

Time on Clobetasol propionate when people have Skin blushing/flushing *:

  • < 1 month: 75 %
  • 1 - 6 months: 25 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Skin blushing/flushing when taking Clobetasol propionate *:

  • female: 69.77 %
  • male: 30.23 %

Age of people who have Skin blushing/flushing when taking Clobetasol propionate *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 5.41 %
  • 20-29: 0.0 %
  • 30-39: 10.81 %
  • 40-49: 10.81 %
  • 50-59: 24.32 %
  • 60+: 48.65 %

Common drugs people take besides Clobetasol propionate *:

  1. Omeprazole: 8 people, 17.39%
  2. Ondansetron: 8 people, 17.39%
  3. Simvastatin: 8 people, 17.39%
  4. Methylprednisolone: 7 people, 15.22%
  5. Sodium Chloride: 7 people, 15.22%
  6. Acyclovir: 7 people, 15.22%
  7. Calcium Gluconate: 7 people, 15.22%
  8. Carboplatin: 7 people, 15.22%
  9. Chlorpheniramine Maleate: 7 people, 15.22%
  10. Dexamethasone: 7 people, 15.22%

Common side effects people have besides Skin blushing/flushing *:

  1. Dizziness: 13 people, 28.26%
  2. Nausea (feeling of having an urge to vomit): 13 people, 28.26%
  3. Diarrhea: 12 people, 26.09%
  4. Fatigue (feeling of tiredness): 12 people, 26.09%
  5. Breathing Difficulty: 11 people, 23.91%
  6. Rashes (redness): 11 people, 23.91%
  7. Nausea And Vomiting: 10 people, 21.74%
  8. Hypokalemia (low potassium): 8 people, 17.39%
  9. Pancreatitis Chronic (chronic inflammation of pancreas): 7 people, 15.22%
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 15.22%

Common conditions people have *:

  1. High Blood Cholesterol: 13 people, 28.26%
  2. Pain: 10 people, 21.74%
  3. Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 7 people, 15.22%
  4. Diarrhea: 7 people, 15.22%
  5. Metastases To Bone (cancer spreads to bone): 7 people, 15.22%
  6. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 15.22%
  7. Nausea (feeling of having an urge to vomit): 6 people, 13.04%
  8. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 4 people, 8.70%
  9. Nausea And Vomiting: 4 people, 8.70%
  10. Diabetes: 4 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Clobetasol propionate and have Skin blushing/flushing?

Check whether Skin blushing/flushing is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Skin blushing/flushing and when was it recovered:

Expand to all the drugs that have ingredients of clobetasol propionate:

Alternative drugs to, pros and cons of Clobetasol propionate:

Common Clobetasol propionate side effects:

Browse all side effects of Clobetasol propionate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Skin blushing/flushing treatments and more:

COVID vaccines that are related to Skin blushing/flushing:

Common drugs associated with Skin blushing/flushing:

All the drugs that are associated with Skin blushing/flushing:

Common conditions associated with Skin blushing/flushing:

All the conditions that are associated with Skin blushing/flushing:

How the study uses the data?

The study uses data from the FDA. It is based on clobetasol propionate (the active ingredients of Clobetasol propionate) and Clobetasol propionate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: